Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Oct;12(10):791-808.
doi: 10.1038/nrd4000.

Applying insights from biofilm biology to drug development - can a new approach be developed?

Thomas Bjarnsholt  1 , Oana Ciofu, Søren Molin, Michael Givskov, Niels Høiby
Affiliations
Review

Applying insights from biofilm biology to drug development - can a new approach be developed?

Thomas Bjarnsholt et al. Nat Rev Drug Discov. 2013 Oct.

Abstract

Most of the research on bacterial pathogenesis has focused on acute infections, but much less is known about the pathogenesis of infections caused by bacteria that grow as aggregates in biofilms. These infections tend to be chronic as they resist innate and adaptive immune defence mechanisms as well as antibiotics, and the treatment of biofilm infections presents a considerable unmet clinical need. To date, there are no drugs that specifically target bacteria in biofilms; however, several approaches are in early-stage development. Here, we review current insights into biofilm physiology and pathology, and discuss how a deep insight into the physical and biological characteristics of biofilms can inform therapeutic strategies and molecular targets for the development of anti-biofilm drugs.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Environ Microbiol. 2011 Jul;13(7):1666-81 - PubMed
    1. APMIS. 2002 Dec;110(12):881-91 - PubMed
    1. Annu Rev Microbiol. 1995;49:711-45 - PubMed
    1. J Cyst Fibros. 2009 Sep;8(5):295-315 - PubMed
    1. FEMS Immunol Med Microbiol. 2011 Jun;62(1):49-56 - PubMed

Substances